Please assess the completion status of the following clinical trial:

Trial Title: Fluorescence Cholangiography During Cholecystectomy - a RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient scheduled for planned laparoscopic cholecystectomy by one surgeon~* Complicated gallstone disease~Exclusion Criteria:~* Open cholecystectomy~* Allergy towards iodine, urografin or indocyanine green~* Liver or renal insufficiency~* Thyrotoxicosis~* Pregnancy or lactation~* Legally incompetent for any reason~* Withdrawal of inclusion consent at any time

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluorescence cholangiography (Type: EXPERIMENTAL): After induction of anaesthesia 2.5-7.5 mg of indocyanine green (0.05 mg/kg) is injected intravenously. The operation field is routinely inspected in the fluorescence imaging mode before dissection of Calot´s triangle. During dissection, the fluorescence imaging mode is used when needed, before division of any tubular structure and after division of the cystic duct and artery.
- X-ray cholangiography (Type: ACTIVE_COMPARATOR): The cholangiography is performed after dissection of the cystic duct by cannulation of the cystic duct with a catheter using either a Kumar- or Olsen grasper. A mobile X-ray C-arm system is used, and the monochrome X-ray image is shown on a separate screen. After satisfactory identification of the extra-hepatic biliary ducts, the intraoperative cholangiography is discontinued and the gallbladder is removed in a standardized manner.

Based on this trial design, predict the completion outcome and termination type (if applicable).